Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 9/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.37 |
| ▸ | CNR2 | P34972 | 5/20 | 0.37 |
| ▸ | CNR1 | P21554 | 3/20 | 0.37 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.33 |
| ▸ | CETP | P11597 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6753578 | 0.91 | SLC6A3 (0.36) | SLC6A4SLC6A3SLC6A2L3MBTL1 | |
| SCHEMBL29214529 | 0.90 | SLC6A3 (0.37) | SLC6A4SLC6A3SLC6A2L3MBTL1 | |
| SCHEMBL6751683 | 0.90 | SLC6A4 (0.36) | SLC6A4SLC6A3SLC6A2L3MBTL1 | |
| SCHEMBL6749694 | 0.85 | SLC6A4 (0.33) | SLC6A4SLC6A3 | |
| SCHEMBL8963206 | 0.82 | CNR1 (0.37) | SLC6A4SLC6A3CNR2CNR1S1PR5 | |
| SCHEMBL28984526 | 0.79 | ALDH1A1 (0.39) | SLC6A4SLC6A3CNR2CNR1SLC6A2 | |
| SCHEMBL3665645 | 0.78 | APOBEC3G (0.36) | — | |
| SCHEMBL6752426 | 0.78 | — | — | |
| SCHEMBL9333940 | 0.76 | CNR1 (0.38) | SLC6A4SLC6A3CNR2CNR1SLC6A2 | |
| SCHEMBL10429831 | 0.76 | SLC6A4 (0.34) | SLC6A4SLC6A3CNR2CNR1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2484658-B1 | LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2017-12-06 | — | — | EP | disclosed |
| US-9109157-B2 | Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition and liquid crystal display device using the same | JNC CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| EP-2484658-A1 | LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2012-08-08 | — | — | EP | disclosed |
| US-20120190897-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190897-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | H1-0, EFHD2, CCND2 | SLC6A4 2580/4885SLC6A3 2635/4885CNR2 680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.